9/28/2009
Abbott to Acquire Solvay Pharmaceuticals Business - Abbott Press Release
September 28, 2009 - Solvay t... Read More
9/24/2009
Athens, Georgia – September 24, 2009 -- ArunA Biomedical, Inc., today announced the signing of a product manufacturing and distribution agreement with Life Technologies Corporation headquartered in Carlsbad, CA. The non-exclusive multi-year agreement includes ArunA’s human neural ce... Read More
9/24/2009
ATLANTA – September 24, 2009 - GeoVax Labs, Inc. (OTC BB: GOVX) (the “Company”), an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), was pleased to hear the announcement today of partial success in the recently... Read More
9/17/2009
BOSTON, MA - FreeMind Group is pleased to announce that seven BIO affiliate organizations, TCM (Maryland), VaBIO (Virginia), NCBIO (North Carolina), BioFlorida (Florida), GaBio (Georgia), IHIF (Indiana) and WBBA (Wash... Read More
9/16/2009
Athens, Georgia – September 16, 2009 -- ArunA Biomedical, Inc., today announced that its Board of Directors has engaged RiversEdge BioVentures to evaluate strategic alternatives for the stem cell tools company. This will include the evaluation of potential fund raising opportunities... Read More
9/14/2009
Atlanta – Emory University is launching a new master of arts degree program in bioethics, which will provide advanced interdisciplinary Read More
9/9/2009
ATLANTA, GA – In the only study of its kind, researchers at the Yerkes National Primate Research Center, Emory University, have documented the first example of a n... Read More
9/3/2009
Atlanta – University System of Georgia Chancellor Erroll B. Davis Jr. announced today that he has appointed Dr. James N. Thompson to serve as interim president of the Medical College of Georgia, Augusta.
Dr. Thompson, an otolaryngologist and former medical school dean who... Read More
8/25/2009
August 25, 2009 - Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
CardioMEMS, Inc.,... Read More
8/10/2009
August 10, 2009 8:29 P.M. A Seattle-based biotechnology company plans to manufacture a cancer-fighting drug at a plant in Union City, but the number of jobs the move brings will depend on FDA approval of the new pharmaceutical.
Dendreon Corp. is building the $70 million plant at the... Read More
7/30/2009
PARIS, FRANCE, WHITEHOUSE STATION, NJ and KENILWORTH, N.J. - Read More
7/28/2009
ATLANTA – In its annual grading of state business climates released on Friday, cable-network CNBC ranked Georgia’s workforce best in the nation. In addition to workforce, Georgia scored highly in the cost of living category and transportation and infrastructure ranking.
Read More
6/30/2009
Georgia’s public-private effort to create new technology-based companies out of local university research has gotten a financial endorsement from the investment community.
The Georgia Research Alliance announced Monday that its GRA Venture Fund has raised $11.25 million from venture capit... Read More
6/25/2009
ATLANTA – (June 25, 2009) – Saint Joseph’s Translational Research Institute (SJTRI), the research division of Saint Joseph’s Health System, announced today that Jai Pal Singh, Ph.D., will join SJTRI as chief scientific officer. Dr. Singh was most recently with Eli Lilly and Compa... Read More
6/16/2009
Atlanta, Ga. – AerovectRx was recently awarded a Georgia Research Alliance Phase III VentureLab award of $250,000 to commercialize AerovectRx’s aerosol drug delivery technology.
GRA VentureLab is the signature commercialization program of the Georgia Research Alliance... Read More
5/21/2009
Atlanta, Ga., (May 21, 2009) – The 2009 BIO International Convention, produced by the Biotechnology Industry Organization (BIO), wrapped up today at the Georgia World Congress Center with 14,352 industry leaders from 58 countries and 48 states.
“The 2009 BIO Inte... Read More
5/19/2009
Atlanta, Ga., May 19, 2009 – Stephen Trusheim, a senior from the Breck School in Golden Valley, Minn., has won the sanofi-aventis International BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of biotechnology through science... Read More
5/19/2009
ATLANTA – Georgia Governor Sonny Perdue announced today that four of Georgia’s leading research and health care organizations have joined together to create an innovative new center that will accelerate the development and commer... Read More
5/19/2009
ATLANTA – Governor Sonny Perdue announced today that two of the world’s leading vaccine research centers will combine their expertise to establish an international research program leading to the development of new hum... Read More
5/18/2009
Atlanta, GA - SEBIO, a public/private partnership formed in 1999 to promote the growth of the life sciences economy in the Southeast, has named Jennifer Moore, Ph.D., as its new Executive Director. Dr. Moore replaces Stephanie Adams, SE BIO's second Executive Director.
... Read More
5/18/2009
ATLANTA — Governor Sonny Perdue today welcomed the 2009 BIO International Convention to Atlanta. 2009 BIO takes place May 18 through May 21 and is expected to draw up to 15,000 industry professionals in the biosciences, one of Georgia’s fastest-growing industries.
... Read More
5/18/2009
ATLANTA – Today Governor Sonny Perdue announced the launch of the first-of-its-kind research tool, iResearchGeorgia. The online, free database is the only one in the U.S. that combines the research capabilities of multiple public and private universities within a single state.Read More
5/18/2009
ATLANTA (May 18, 2009) — Sciele Pharma, Inc. (Head Office: Atlanta, Georgia, USA; CEO and Chairman: Patrick P. Fourteau; hereafter “Sciele”), a U.S.-based group company of Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) and Victory Phar... Read More
5/14/2009
BRUSSELS - May 14, 2009 - UCB announced today that the U.S. Food and Drug Administration (FDA) approved Cimzia®, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). Cimzia® can be d... Read More
5/13/2009
ATLANTA, GEORGIA, PLANTATION, FLORIDA – May 13, 2009 - PerimeterPHARMA Solutions, LLC (“PPS”), a provider of branding and development consulting services to the pharmaceutical and biotechnology industries an... Read More
5/5/2009
Summit to Focus on Food and Fuel Sustainability at 2009 ConventionRead More
5/5/2009
Atlanta, GA (May 5, 2009) - Altea Therapeutics, a leader in advanced transdermal drug delivery systems, announced today senior R&D appointments to strengthen its product development ... Read More
4/27/2009
ATLANTA—Visioneering Technologies Inc. (VTI), a startup company with what it describes as breakthrough technology for correcting presbyopia through contact lenses and other on eye/in eye applications, announced the closing of its Series B round of financing led by MB Ventures of ... Read More
4/23/2009
ATLANTA, GA (April 23, 2009) – The Biotechnology Industry Organization today announced that it has named Georgia Governor Sonny Perdue its 2009 Governor of the Year in recognition of his leadership and support of the biosciences industry gr... Read More
4/22/2009
ATLANTA, GA (April 22, 2009) – Georgia Bio (GaBio) congratulates Johnny Fells III of Northside High School, Warner Robin... Read More
4/21/2009
WASHINGTON, D.C. (April 21, 2009) – The Biotechnology Industry Organization (BIO) announced today that Andrew Young, Jr., Former U.S. Ambassador to the United Nations, will present the keynote address at the Leadership Summit on Food and Fuel Substantiality at the 2009 BIO Intern... Read More
4/21/2009
Washington, D.C. [April 21, 2009] – The Biotechnology Industry Organization (BIO) has announced the four winners of the Be the Buzz of BIO contest – a competition which companies entered in order to wi... Read More
4/13/2009
ATLANTA - Emory University's Winship Cancer Institute has earned the coveted National Cancer Institute Cancer Center designation. Winship is the first medical facility in Georgia to earn this distinction. As an NCI designated center, Winship joins an elite group of 64 cancer cent... Read More
4/9/2009
ATLANTA, GA (April 9, 2009) – Seven high school students from five states will compete Monday, April 20, in the Southeastern regional finals of the 2009 sanofi-aventis International BioGENEius Challenge in Atlanta. The competition, condu... Read More
4/8/2009
ATLANTA, GA (April 8, 2009) – Georgia Bio applauds the General Assembly for adopting legislation that exempts from sales tax free samples of prescription drugs and biologics and of investigational products in clinical trials and ap... Read More
4/7/2009
ATLANTA, GA (April 7, 2009) – Georgia Bio presented its annual student science award, sponsored by Merial Ltd., to Dunwoody High School sophomore Lauren Fleck at the Georgia Science and Engineering Fair (GSEF) April 4.Ms. Fleck’s project was “Can a VP Shunt Malfunction be ... Read More
4/1/2009
WASHINGTON, D.C. (April 1, 2009) – With nearly one-third of all 2009 BIO International Convention attendees representing organizations located outside of the U.S., the Biotechnology Industry Organization (BIO) announced today that May 20th will be International Day at this year’s... Read More
4/1/2009
ATLANTA, Ga., April 1, 2009. Altea Therapeutics announced today that it has entered into an agreement with Eli Lilly and Company and Amylin Pharmaceuticals, Inc. to develop and commercialize a novel daily transdermal patch delivering sustained levels of exenatide utilizing the Al... Read More
3/31/2009
WASHINGTON, D.C. (March 31, 2009) – The Biotechnology Industry Organization (BIO) today announced that The B-52s will be performing during the 2009 BIO International Convention Welcome Reception. The reception... Read More
3/31/2009
Athens, Georgia - - March 31, 2009. ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has submitted a Department of Defense contract proposal to develop an envir... Read More
3/30/2009
Athens, Georgia - - March 30, 2009. ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has co-developed a validated kit to produce induced pluripotent stem cells ... Read More
3/30/2009
ATLANTA – Researchers at the Yerkes National Primate Center, Emory University, have discovered a compound used to diagnose Alzheimer’s disease in humans may also be useful in determining why humans develop the disease and other primates do not.... Read More
3/27/2009
Athens, Georgia – March 27, 2009 -- ArunA Biomedical, Inc., announced today that it will make its CEL... Read More
3/25/2009
Washington, D.C. [March 25, 2009] – The Biotechnol... Read More
3/23/2009
Athens, Georgia - - March 23, 2009 - - ArunA Biomedical, Inc., announced today an agreement with Neuromics, Inc. of Edina, MN, givin... Read More
3/19/2009
Washington, D.C. and Atlanta, GA (March 19, 2009) – By hosting the 2009 BIO International Convention in Atlanta, Ga., May 18-21, the Biotechnology Indu... Read More
3/11/2009
Washington, D.C. [March, 11, 2009] – The Biotechnology Industry Organization (BIO) announced today that Sir Elton John will be a keynote speaker at the 2009 BIO International Convention. This year's global event for biotechnology will take place on May 18-21, 2009, at the Georgia W... Read More
3/9/2009
WASHINGTON, D.C. and ATLANTA, GA (March 9, 2009) – SEBIO and BIO announce today the signing of a trade agreement with the primary goal to showcase the Southeast’s life sciences industry to the world in conjunction wi... Read More
3/9/2009
WASHINGTON, D.C. (March 9, 2009) – The Biotechnology Industry Organization (BIO) lauded President Barack Obama’s Executive Order to allow the National Institutes of Health (NIH) to fund research using embryonic stem cells. The NIH was ... Read More
2/9/2009
New York, February 9, 2009 - The biotechnology industry is expected to rebound and outperform healthcare and the rest of the market this year, according to findings from an investor perception study released today by Thomson Reuters and the Biotechno... Read More
2/4/2009
Gaithersburg, MD and Atlanta, GA, February 4, 2009 – Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, and Expression Therapeutics, a biotechnology company specializing in factor VIII-based therape... Read More
1/30/2009
Athens, Georgia – January 30, 2009 -- ArunA Biomedical, Inc., announced today that it will make its h... Read More
1/23/2009
ATLANTA – Governor Sonny Perdue today announced $1.6 million in federally-funded grants to four Georgia regions working toward earning Work Ready R... Read More
1/22/2009
ATLANTA– Georgia Governor Sonny Perdue recently announced he is proposing tort reform legislation that will protect Georgia-based biotech companies from product liability claims. “With this proposed legislation, we will cement our position as a leader in the biotech indu... Read More
1/14/2009
ATLANTA, GA (January 14, 2009) -- Each year Georgia Bio (GaBio) rec... Read More
1/13/2009
ATLANTA, GA (January 13, 2008) – The Biotechnolog... Read More
1/13/2009
ATLANTA, GA (January 12, 2009) Grace Powers, a Regulatory Affairs Specialist at CardioMEMS, Inc. was named the 2009 Emerging Leader of the Year by Georgia Bio (GaBio). She will be honored at the GaBio Annual Awards... Read More
1/12/2009
ATLANTA, GA (January 12, 2009) -- Georgia Bio (GaBio) announced winners of its 2009 Deal of the Year awards in four categories: Merger/Acquisition; Diagn... Read More
12/23/2008
ATLANTA, GA (December 23, 2008) – Kenneth C. Stewart, Commissioner of the Georgia Department of Economic Development, and Thomas H. Callaway, M.D., Presi... Read More
12/18/2008
Atlanta, GA-SEBIO announced four winners of the Second Annual SEBIO Awards in a ceremony held at its Tenth Anniversary Investor Forum in Palm Beach, FL on December 5th. The awards honored companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE... Read More
9/29/2008
WASHINGTON - During its 2008 annual meeting, the National Academy of Engineering (NAE) will present two awards for extraordinary impacts on the engineering profession. NAE’s Founders Award will be given to ROBERT M. NEREM, who has made important contributions to the field of bioengineering. G. ... Read More
9/23/2008
ATLANTA, GA (September 23, 2008) – The Georgia Life Sciences Summit Wednesday, September 24, will feature release of Shaping Infinity, the Georgia Life Sciences Industry Analysis 2008. The report reveals there are nearly 300 life sciences companies in Georgia, employing ... Read More
9/22/2008
ATLANTA, GA (Sept 22, 2008) – Georgia Bio, the non-profit, membership-based organization that represents the interests of the life science industry in Georgia, has welcomed nine industry leaders to its Board of Directors in 2008.The new Directors are: Stephen ... Read More
9/16/2008
Atlanta, GA, September 16, 2008: Leaders from the international biotechnology and pharmaceutical industries gathered last week for the first annual BioPharm America™ partnering conference. The conference was held on September 9–10 in Atlanta, Georgia. BioPharm America drew... Read More
9/12/2008
Atlanta Business Chronicle - by Martin Sinderman Contributing WriterHopes are high that an upcoming convention will raise the profile and provide numerous spinoff benefits for Georgia’s already robust bioscience industry.More than 20,000 biotechn... Read More
9/8/2008
ATLANTA (September 8, 2008) –The 8th Annual Georgia Life Sciences Summit, September 24, at the Georgia World Congress Center, will feature more than 70 speakers discussing trends and issues and showcasing the most advanced research and product developments in biomedicine, medical... Read More
9/2/2008
WALTHAM, Mass., September 2, 2008 -- Synageva BioPharma announced today the appointment of Sanj K. Patel as President and Chief Executive Officer. Patel, who joins Synageva from Genzyme Therapeutics, brings expe... Read More
9/1/2008
ATLANTA & OSAKA, Japan--(BUSINESS WIRE)--Sept. 1, 2008--Shionogi & Co., Ltd. and Sciele Pharma, Inc. (NASDAQ:SCRX) today announced that they have entered into a definitive agreement under which Shionogi & Co., Ltd. will... Read More
8/28/2008
Atlanta (August 28, 2008) — Mostafa El-Sayed, Regents Professor in Georgia Tech’s School of Chemistry and Biochemistry, has just been awarded the 2007 Medal of Science, the nation’s highest honor in the field.Mostafa El-Sayed received the nation’s highest honor in science, ... Read More
8/22/2008
ATLANTA, GA (August 22, 2008) – Georgia Bio announced that the final report of the NSF-supported Educating Biotechnicians for Future Industry Needs conference held in April 2008 is available on the Georgia Bio website at http... Read More
8/21/2008
ATLANTA (August 21, 2008) – Georgia Governor Sonny Perdue will deliver a keynote address at the 2008 Georgia Life Sciences Summit September 24 at the Georgia World Congress Center. Governor Perdue’s remarks will precede a special program in the afternoon ... Read More
8/20/2008
ATLANTA, GA, August 20, 2008 – GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta basedbiopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, is pleased to announce the addition of Peter M. Tsol... Read More
8/20/2008
GREENFIELD, Ind., Aug 20, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Elanco, a division of Eli Lilly and Company (NYSE: LLY), today announced that Lilly has signed an agreement to acquire the... Read More
8/8/2008
ATLANTA, Ga., August 8, 2008. Altea Therapeutics announced today that several pre-eminent medical practitioners and scientists in the fields of drug delivery, skin physiology, engineering, and clinical medicine have joined its new Scientific Advisory Board. Professor Richard H. G... Read More
8/4/2008
University of Georgia researchers working to unlock the secrets of embryonic cells have been awarded a $9.2 million grant by a division of the National Institutes of Health (NIH), the university announced Monday.The grant, awarded by NIH’s National Institute of G... Read More
7/29/2008
BUFORD, Ga.--(BUSINESS WIRE)--July 29, 2008--Theragenics Corporation(R) (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, announced today that it completed the acquisition of NeedleTech Products, Inc., on July 28, 2008. The... Read More
7/24/2008
ATLANTA, GA (July 24, 2008) – Georgia Bio applauds the State Board of Education for its approval of a high school curriculum for a Biotechnology Research and Development Career Pathway, scheduled for launch in the fall 2009. Initially approved under the Career, Technical and Agricultural Educatio... Read More
7/23/2008
ATLANTA (July 23, 2008) – Senator Bob Dole and Atlanta Mayor Shirley Franklin lead a stellar line-up of speakers for the 2008 Georgia Life Sciences Summit September 24 at the Georgia World Congress Center.Read More
7/22/2008
ATLANTA (GA - USA) & NANTES (France) July 22, 2008 -- GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, together with VIVALIS (NYSE Euro... Read More
7/11/2008
ATLANTA, July 11, 2008 — Forbes Magazine has tapped Georgia as the third best state in the nation for alternative energy from biomass. Also this week, cable news and business channel CNBC ranked Georgia in the top ten and second in the Southeast in its annual rankings of “America... Read More
7/8/2008
COLUMBIA, S.C. – (July 8, 2008) – Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic and knowledge discovery software, announced today that the National Center for Research Resources (NCRR), of the National Institutes of Health (NIH), has chosen the company to de... Read More
7/7/2008
ATLANTA, GA, July 7, 2008 – GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta based, publicly traded biopharmaceutical company specializing in the prevention and treatment of infectious diseases, today provided an operational update on the company’s progress towards entering Phase 2 prev... Read More
7/2/2008
ATLANTA, Ga., July 2, 2008. Altea Therapeutics announced today that it has entered into apartnership with Hospira, Inc., a global specialty pharmaceutical and medication deliverycompany, for the development and commercialization of an undisclosed product utilizing theRead More
6/24/2008
ATLANTA, GA (June 24, 2008) – In conjunction with the state’s Work Ready initiative for improved workforce across the state of Georgia, communities and organizations within the identified Innovation Crescent region made history on Tuesday, launching Geor... Read More
6/23/2008
Atlanta, GA – Georgia Bio (GaBio) congratulates Mingjuan “Lisa” Zhang of North Carolina School of Science & Mathematics, Durham, N.C., for winning the 2008 sanofi-aventis International BioGENEius Challenge, conducted by the Arlington, Va.-based Biotechnology Institute.<... Read More
6/20/2008
ATLANTA – Today the U.S. Department of Homeland Security issued the Draft Environmental Impact Statement for the sites competing for the National Bio and Agro-Defense Facility (NBAF). Governor Perdue issued the following statement. “Georgia continues to enjoy great succes... Read More
6/19/2008
SAN DIEGO, Calif. — Governor Sonny Perdue announced today that DocuSys, Inc., the leading anesthesia information management system (AIMS), medication management system and presurgical care management system provider, plans to relocate its headquarters to Atlanta. This move will crea... Read More
6/19/2008
SAN DIEGO, Calif. – Governor Sonny Perdue announced today that Dicon Technologies, Inc., a medical component manufacturer and a supplier to U.S. troops, will construct a new facility in coastal Bryan County. The company will create up to 100 jobs in the next five years and invest al... Read More
6/18/2008
SAN DIEGO, June 18 /PRNewswire/ -- Governor Sonny Perdue today announced that Georgia will be home to the new National Health Museum (NHM). The museum, which will be located in downtown Atlanta, is expected to bring 135 jobs and approximately $230 million in initial investment to th... Read More
6/17/2008
ATLANTA – Today after concluding a successful inaugural SEUS-Canadian Provinces Alliance Conference in Savannah, Governor Sonny Perdue will now turn his attention to the 2008 BIO International Convention in San Diego. Georgia’s biosciences industry, ranked seventh in the country... Read More
6/15/2008
By BOB KEEFEThe Atlanta Journal-ConstitutionSan Diego — Georgia has world-class universities, the Centers for Disease Control and Prevention, and cutting-edge companies working on cures for everything from AIDS to diabetes. But when it comes to the biotech busines... Read More
6/5/2008
ATLANTA, Ga. (June 5, 2008) - Governor Sonny Perdue will lead a delegation of Georgians to San Diego this month to participate in the 2008 Biotechnology Industry Organization International Convention, the largest biotech conference in the world.The BIO convention, June 17-20, is expected t... Read More
6/4/2008
Atlanta – Georgia will showcase its bioscience leadership at the 2008 Biotechnology Industry Organization’s International Convention, on June 17 – 20, in San Diego, Calif. Governor Perdue will deliver a keynote address on June 19 and meet with State and commerce leaders during t... Read More
6/4/2008
ATLANTA, June 4, 2008 – PharmaCentra, an Atlanta-based marketing and services firm that provides customizable healthcare management programs for the pharmaceutical industry, announced today it is expanding its domestic operations center network with a new location in Americus. Read More
4/24/2008
DECATUR, GA – The Private Hospital Authority of DeKalb County (PHADC) has awarded a $15,000 grant to the Institute for Bioengineering and Bioscience (IBB) to develop biotechnology modules or kits for use in local area schools. The program development is three-fold. First... Read More
4/21/2008
ATLANTA, GA (April 21, 2008) – Georgia Bio (GaBio) congratulates Noel Arthur Turner of Satellite High School, Satellite Beach, Fla., and Mingjuan “Lisa” Zhang of North Carolina School of Science & Mathematics, Durham, N.C., for winning the Southeast regional ... Read More
4/13/2008
ATLANTA, GA (April 14, 2008) – Nine high school students from six states will compete... Read More
3/25/2008
ATLANTA - GeoVax Labs, Inc. http://www.geovax.com, an Atlanta based AIDS vaccine development company, is very pleased to announce the addition of Dr. Robert McNally as President and CEO effective 01 April 2008. Current President/CE... Read More
3/18/2008
ATLANTA, March 18, 2008—Alimera Sciences today announced that it has closed a Series C financing round of $30 million with all five of the company’s existing venture capital firms exercising the right to participate at their full pro rata share.The proceeds from the Seri... Read More
3/17/2008
ATLANTA, GA – Georgia Bio (GaBio) is pleased to announce today that Fish & Richardson has joined the association as a Champion Sponsor, contributing $50,000 to support GaBio’s efforts to grow the life sciences industry and prepare to host the 2009 Biotechnology Industry Organization Internat... Read More
3/10/2008
ATLANTA, GA – Georgia Bio (GaBio) is pleased to announce today that KPMG LLP, the audit, tax and advisory firm, has joined the association as a Champion Sponsor, contributing $50,000 to support GaBio’s efforts to grow the life sciences industry and prepare to host the 2009 Biotechnology Industry... Read More
2/13/2008
Atlanta, Ga., February 13, 2008. Altea Therapeutics announced today that Dr. Richard Guy, Professor of Pharmaceutical Sciences and the Head of the Department of Pharmacy & Pharmacology at the University of Bath, has joined the Company’s Scientific Advisory Board. “Richard Guy is a le... Read More
2/11/2008
Atlanta, GA – Southeast BIO (SEBIO) today announced its 2008 SEBIO Investor Forum, set for December 4-5, 2008, at the Breakers Resort in Palm Beach, FL. The chair of this year’s event is David Day, Director, Office of Technology Licensing, University of Florida.The annual... Read More
2/7/2008
ATLANTA, Ga. (February 7, 2008) - Rep. Charlice Byrd filed House Bill 1095, calling for establishment of a Georgia Innovation Center “to help make Georgia a national leader in the area of science innovation and a desirable location for innovative educational and business entities... Read More
2/6/2008
ATLANTA, Feb. 7 - Dr. Harriet Robinson, lead scientist and co-founder of GeoVax Labs, Inc., (OTC BB: GOVX) an Atlanta-based biotechnology company developing HIV/AIDS vaccines, co-presented successful Phase I trial results at the 15th Conference on Retroviruses and Opportunistic I... Read More
1/25/2008
ATLANTA, GA -- Each year Georgia Bio (GaBio) recognizes individuals, companies or institutions for significant contributions to Georgia’s life sciences industry with its Georgia Bio Community Awards. The 2008 winners are Georgia State Representative Charlice Byrd; Carl V. Patton, Ph.D., Georgia S... Read More
1/24/2008
ATLANTA, GA – Georgia Bio (GaBio) and several partner organizations are part of an effort to accelerate development of the bioscience workforce in Georgia with funding from a $500,000 Work Ready Region (WRR) grant awarded by Governor Sonny Perdue through his Office of Workforce Development.Read More
1/24/2008
ATLANTA, GA - Stephen MacDonald, Ph.D., a patent agent for King & Spalding, was named the 2008 Emerging Leader of the Year by Georgia Bio (GaBio). He was honored Thursday evening at GaBio’s Annual Awards Dinner with more than 400 life sciences professionals in attendance.The Emerging L... Read More
1/16/2008
Arlington, Va. – The Biotechnology Institute, the national biotechnology education organization, has entered into an agreement with the National Academies to distribute Science, Evolution, and Creationism to top leaders of biotechnology companies and to members of its large national network of te... Read More
1/11/2008
ATLANTA, GA (January 11, 2008) -- Georgia Bio (GaBio) announced four winners of the 2008 Deal of the Year awards. The companies reflect a broad range of activity and demonstrate the diversit... Read More
1/3/2008
ATLANTA, GA (January 4, 2008) – H. Lee Herron, DVM, General Manager of Biosciences for Georgia Institute of Technology's Enterprise Innovation Institute, and Phi... Read More
12/17/2007
ATLANTA, GA (Dec. 17, 2007) – UCB’s U.S. President Fabrice Egros, Ph.D., and Altea Therapeutics President and CEO Eric Tomlinson, DSc, Ph.D., were elected co-chairs of Georgia Bio’s Board of Directors for 20... Read More
12/5/2007
Atlanta, GA, December 5, 2007 – Metastatix, Inc., an emerging pharmaceutical... Read More
12/4/2007
Atlanta – December 4, 2007. CardioMEMS, Inc., the pioneer in wireless sensing for the management of chronic cardiovascular diseases such as Heart Failure, today announced the closing of its Series E Preferred Stock financing for $33 million of equity funding led by Arcapita Ventu... Read More
12/3/2007
Rockville, MD, December 3, 2007 -- BioReliance Corporation announced today that David A. Dodd has been named President, Chief Executive Officer and Chairman of the Board of the Company, effective today. BioReliance Corporation is a leading contract services company that provides ... Read More
11/29/2007
November 29, 2007- Atlanta, GA— Southeast BIO (SEBIO) announced four winners of the First Annual SEBIO Awards in a ceremony held at its Ninth Annual Investor Forum in Pinehurst, NC on November 8th. The awards honored companies in the following categories: Southeast (SE) Deal of the Year: Initial ... Read More
11/27/2007
November 27, 2007- Atlanta, GA-- More than 400 people attended the Ninth Annual Southeastern BIO Investor Forum on November 7th-8th in Pinehurst, North Carolina. The Forum is the Southeast’s premier life sciences venture capital conference.“The success of this year's Forum is a testament ... Read More
11/1/2007
WHITEHOUSE STATION, NJ / DULUTH, GA, USA — The millions of pet owners who seek expert, in-depth information to help keep the animals in their lives healthy can now turn to a source based on the one used by their veterinarians. The Merck/Merial Manual for Pet Health is the first complete hea... Read More
11/1/2007
Company posts third quarter net income of $1.9 million and $0.07 per share compared to $2.0 million and $0.07 per share in 2006; Non-GAAP EPS for third quarter was $0.09 compared to $0.00 per share in 2006<... Read More
11/1/2007
BUFORD, Ga.--(BUSINESS WIRE)--Nov. 1, 2007--Theragenics Corporation(R) (NYSE: TGX), a medical device company serving the prostate cancer treatment and surgical products markets, today announced consolidated financial results for t... Read More
10/30/2007
ATLANTA, Ga., October 30, 2007. Altea Therapeutics has achieved sustained and steady basal levels of insulin in patients with type 1 diabetes using a small transdermal patch delivering recombinant human insulin in a cost-effective manner. These results were presented this week at... Read More
10/16/2007
Atlanta, GA, October 16, 2007 – Metastatix, Inc., an ... Read More
10/16/2007
SAN FRANCISCO, Oct. 16 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of life sciences and healthcare services, industrial technology, business services and software, today announced that it has formed a strategic relatio... Read More
10/12/2007
October 12, 2007-For Immediate ReleaseBorsa Italiana SpA, the company that runs the Milan stock exchange, said it had admitted Bouty Healthcare SpA to trading on its Expandi segment of the market for small- and medium-sized companies.The operation, coordinated by Intermonte in qualit... Read More
10/9/2007
Atlanta, GA, October 9, 2007 – Metastatix, Inc., an emerging pharmaceutical company focused on the development of small molecule therapeutics, announced today it has secured $35 million in Series B financing. The new round of funding primarily will be used to conduct clinical tri... Read More
10/5/2007
ATLANTA (October 5, 2007) -- The 7th Annual Georgia Life Sciences Summit achieved another milestone, setting records for attendance and program excellence.Read More
10/1/2007
ATLANTA (October 1, 2007) – The Georgia Life Sciences Summit Wednesday, October 3, will feature the release of Shaping Infinity, the Georgia Life Sciences Industr... Read More
9/26/2007
ATLANTA, Ga., 26 Sept 2007 – GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta based biotechnology company, announced receipt of an estimated $15,000,000 Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant to support its HIV/AIDS vaccine program. This large ... Read More
9/25/2007
ATLANTA (September 26, 2007) – An exploration of cancer research advances by three renowned scientists will be among the special features of the 7th Annual Georgia Life Sciences Summit October 3 at the Georgi... Read More
9/18/2007
ATLANTA (September 18, 2007) -- The 7th Annual Georgia Life Sciences Summit, October 3, at the Georgia World Congress Center, will feature more than 40 speakers exploring trends and issues in biomedicine, medical devices, agricultural biotechnology, food nutrition and biofuels.The 2007 t... Read More
9/11/2007
ATLANTA--(BUSINESS WIRE)--Sept. 11, 2007--Inhibitex, Inc. (Nasdaq: INHX) announced today that it has entered into an exclusive worldwide license agreement with the University of Georgia Research Foundation (UGARF) for intellectual property covering a series of HIV integrase inhibitors and other anti... Read More
9/10/2007
Atlanta, GA – Southeast BIO (SEBIO) announced today it has selected 24 companies to participate in its Southeastern BIO Investor Forum, an event that brings together the Southeast's most promising life sciences venture opportunities with the regional and national venture capital community. The SEBIO... Read More
9/5/2007
Atlanta, Ga -- The U.S. biotechnology industry is on track to become a $100 billion business by the end of the decade and nowhere is that more evident than right here in Georgia where the life sciences industry, as a whole, expanded at a much faster pace than the rest of the state’s industry ... Read More
8/13/2007
WASHINGTON, D.C.–AdvaMed 2007, a comprehensive, industry-designed and focused medical technology conference and exhibition today announced the addition of 18 new associations and organization partners from across the country. AdvaMed 2007 will be held at the Ronald Reagan Building and ... Read More
8/9/2007
ATLANTA – Georgia Bio (GaBio) - a new name and identity for the Georgia Biomedical Partnership. The change marks a milestone for the private, non-profit industry association, formed in 1989.The new GaBio, representing more than 290 companies, universities and research insti... Read More
8/1/2007
ATLANTA, GA —Carol Henderson has been named Director of the Innovation & Technology Office at the Georgia Department of Economic Development (GDEcD). “I’m proud to announce Carol Henderson’s elevation to the Director of Innovation & Technology Office,” said Heidi Green, de... Read More
8/1/2007
Duluth, GA - MERIAL® reaches its 10th birthday today, 1 August 2007. The company, a 50:50 joint venture between Merck and sanofi-aventis, is celebrating the milestone under the overall theme of “Shaping Animal Health Together”. This acknowledges the vital interdep... Read More
7/31/2007
ATLANTA, Ga. – GeoVax Labs, Inc. (OTC:BB GOVX), an Atlanta-based biotechnology company developing human AIDS vaccines, today announced that it has entered into a definitive agreement with PURE Capital LLC, a newly formed investment subsidiary of an established private inves... Read More
7/31/2007
ATLANTA – Gretchen Kuglar Corbin has been named Division Director for International Operations at the Georgia Department of Economic Development.
“I am proud to announce Gretchen Corbin’s promotion to Division Director for International Operations,” said He... Read More
7/17/2007
ATLANTA, Ga.– GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based biotechnology
company, announced an early start of 2 new AIDS vaccine clinical (human) trials. These FDA compliant
trials were previously scheduled to start later in 2007 and are the 3rd and 4th ... Read More
7/16/2007
Atlanta, GA. – Tikvah Therapeutics, Inc. (Tikvah) and Chicago-based Apkarian Technologies, LLC (Apkarian) announced today that Tikvah has entered into an exclusive licensing agreement with Apkarian for patents and patent applications involving certain agonists of specific sites of the NMDA ... Read More
7/12/2007
Atlanta, GA. – Tikvah Therapeutics, Inc., a biopharmaceutical company that focuses on novel therapeutic treatments for diseases of the central nervous system, including neurology and psychiatry disorders, announced today it has completed a privatefinancing with gross procee... Read More
7/9/2007
Athens, GA - Abeome Corporation, a Georgia-based biotech company, today announced the closing of an investment from venture capital firms, Georgia Venture Partners and ATDC Seed Capital fund. The funding follows previous awards from the Georgia Research Alliance for Technology Pa... Read More
6/21/2007
ATLANTA, Ga., 21 June 2007 – GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta based biotechnology company, announced it engaged Althea Technologies, Inc., San Diego, CA, as contract manufacturer for its HIV-1 DNA (AIDS) vaccine. This vaccine will be utilized in GeoVax’s advanced Phase 2 h... Read More
6/5/2007
Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast's life sciences industry, announced today that it has selected ten finalists in its first annual BIO/Plan Competition.
Launched earlier this year by SEBIO and founding sponso... Read More
6/1/2007
Duluth, GA – June 1, 2007 – The Board of Directors of Merial Ltd., one of the world’s leading animal health companies, announced that Jose Barella will succeed Jerry Belle as Executive Chairman of Merial, effective June 1st.
Barella has been serving Merial as Chi... Read More
5/3/2007
ATLANTA, Ga., May 3, 2007. Altea Therapeutics has entered into a research agreement with an undisclosed major pharmaceutical company to examine the feasibility of developing a transdermal patch product that delivers certain macromolecular carbohydrates for the treatment of coagulation disorders. Read More
4/17/2007
ATLANTA, GA (April 17, 2007)– The Georgia Biomedical Partnership congratulates Johnny Fells III of Northside High School in Warner Robbins and Lauren Wooten Smith of Davidson Fine Arts Academy in Augusta for their representation of Georgia in the Southeast regional competition of the Sanofi-A... Read More
4/10/2007
ATLANTA (April 10, 2007) – The Georgia Biomedical Partnership (GBP) strongly urges amending SB 148 to remove unnecessary and hostile references to stem cell research. The GBP supports SB 148’s proposal to establish an umbilical cord blood and postnatal tissue bank for research and medical tr... Read More
4/10/2007
ATLANTA--(BUSINESS WIRE)--April 10, 2007--Inhibitex, Inc. (NASDAQ: INHX) announced today that it has entered into a definitive merger agreement with FermaVir Pharmaceuticals, Inc. (OTCBB: FMVR). FermaVir's development-stage antiviral pipeline includes FV-100, a highly potent nucleoside analogue for ... Read More
4/3/2007
Palo Alto, Calif. — April 3, 2007 — Frost & Sullivan has presented Atlanta-based Altea Therapeutics, with the 2007 Frost & Sullivan Technology Innovation Award in the field of transdermal drug delivery for its development of the PassPort™ System, a new breakthrough technology that enables painless d... Read More
3/26/2007
Duluth, Ga., March 26, 2007 – Merial, the world’s leading animal health company, gained conditional approval from the U.S. Department of Agriculture for a breakthrough vaccine to treat canine melanoma, a common yet deadly form of cancer in dogs. This is the first time that the U.S. governmen... Read More
3/23/2007
Stanford University Medical Center (SUMC) Investigative Review Board (IRB) has officially approved the stroke marker protocol designed to evaluate the utility of the CIS Biotech, Inc. blood tests in diagnosing ischemic stroke and transient ischemic attack.Currently there is no simple blood t... Read More
3/13/2007
ATLANTA, GA (March 13, 2007) – The Biotechnology Industry Organization (BIO) has named Georgia Rep. Charlice Byrd (R-20th District) as a “Legislator of the Year “ for 2007.“The Legislator of the Year award honors public officials for their commitment to advancing life sciences innovat... Read More
3/12/2007
Athens, Ga – Life sciences scholar and author Christopher Thomas Scott will explain the science, outline the issues and discuss the possible achievements of stem cell research as keynote speaker for the University of Georgia’s Regenerative Bioscience Center Symposium on Monday, April 2.His l... Read More
3/8/2007
The world could have a new vaccine designed to kill the AIDS virus in as little as three to four years according to an Atlanta-based group working on the vaccine.It is a scientific advance that could save tens of millions of lives, and it is being developed on the campus of Emory University.... Read More
2/28/2007
MINNEAPOLIS – February 28, 2007– Medtronic, Inc. (NYSE:MDT) announced today the implementation of a succession plan that was developed by the board of directors over the past several years for its chief executive officer and chief operating officer positions. Effective August 23, 2007, at th... Read More
2/22/2007
ATLANTA, GA (February 22, 2007) – The Georgia Biomedical Partnership applauds State Rep. Charlice Byrd (R-20th District) for introduction Wednesday of House Resolution 323. The resolution would form a Georgia Bioeconomic Development Commission charged with adopting a statewide plan to create... Read More
2/22/2007
February 22, 2007-MedAssets Supply Chain Systems and Inviro Medical Devices (www.inviromedical.com) have entered into an agreement that provides MedAssets customers access to Inviro’s extensive portfolio of safety hypodermic needle and syringe produc... Read More
2/20/2007
ATLANTA, GA (February 13, 2007) – Georgia Biomedical Partnership, a non-profit, membership-based organization that represents the interests of the life science industry in Georgia, named 14 new members to its Board of Directors.The new directors are:Gerald Belle, Chairman of M... Read More
2/13/2007
Atlanta, GA (Feb. 13, 2007) – Atlanta-based Tikvah Therapeutics, Inc. has signed a licensing agreement with Therapade Technologies LLC, a drug development company founded by researchers at the Emory University School of Medicine and the College of William and Mary, for worldwide rights to dev... Read More
2/7/2007
ATLANTA, Ga., February 7, 2007 -- Altea Therapeutics today announces the appointment of Dr.William R. Good to its Board of Directors.“We are pleased to welcome such an experienced and successful scientist and thought leader indrug delivery to our Board,” said Dr. Eric Tomlinso... Read More
2/5/2007
Atlanta, Georgia, February 5, 2007 – NeurOp Corporation, a preclinical stage pharmaceutical company focused on next generation drugs for CNS indications, announced today that it has received a Phase 1 SBIR award from the National Institute of Neurological Disorders and Stroke (NINDS). This gr... Read More
2/5/2007
ATLANTA, Ga., February 5, 2007 – GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials. Results from the first low dose trial indicate a good safety profile as well as pos... Read More
2/2/2007
ATLANTA, Ga., February 2 2007 – GeoVax Labs, Inc. (OTC BB: GOVX), an Atlanta based biotechnology company, today reported successful results from a preclinical trial using GeoVax’s vaccines for the therapeutic treatment and prevention of Acquired Immunodeficiency Disease Syndrome (“AIDS”) in n... Read More
2/1/2007
CHARLOTTESVILLE, VA – February 1, 2007 – Southeast BIO (SEBIO), a regional nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today the first annual BIO/Plan Competition. The year-long program has been designed and developed to help p... Read More
1/25/2007
Athens, Georgia - - January 25, 2007 - - Aruna Biomedical, Inc., announced today that it has entered into a technology licensing agreement with the University of Georgia Research Foundation that will enable the company to commercialize human neural progenitor cell technology developed ... Read More
1/23/2007
ATLANTA, GA (January 23, 2007) -- The Georgia Biomedical Partnership (GBP) announced six winners in four categories for the 2007 Deal of the Year awards. The deals reflect a broad range of activity, from university research to vaccine manufacturing, and demonstrate the diversity of Georgia’s ... Read More
1/23/2007
ATLANTA, GA (January 23, 2007) -- Each year the Georgia Biomedical Partnership (GBP) recognizes individuals, companies or institutions for significant contributions to Georgia’s life sciences industry with its Biomedical Community Awards.The 2007 winners are Mike Wanner, CEO of Abeome... Read More
1/22/2007
ATLANTA, GA (January 22, 2007) Melissa Wendt, Director of Health Sciences of Hood Marketing Solutions, was named the 2007 Emerging Leader of the Year by the Georgia Biomedical Partnership (GBP).She was honored at the GBP’s Annual Awards Dinner at the InterContinental Buckhead Hotel. ... Read More
1/18/2007
ATLANTA, Ga., January 18, 2007. Altea Therapeutics has entered into research agreements withtwo undisclosed pharmaceutical companies to examine the feasibility of developing noveltransdermal patch products for two protein drugs.Under the terms of these agreements, Altea Therapeutics ... Read More
12/21/2006
ATLANTA, GA (December 20, 2006) Georgia’s life sciences industry achieved significant milestones in 2006 in the negotiation of major business deals, such as financings, collaborations and acquisitions. The Georgia Biomedical Partnership (GBP) has identified 11 finalists in four categories for... Read More
12/18/2006
The U.S. Department of Labor awarded 72 community college partnerships $125 million for successfully competing under the Presidential Community-Based Job Training Grants initiative. Athens Technical College was awarded $1,996,326 in the area of Biotechnology and this funding will be used to provide... Read More
12/18/2006
Stem Cell Sciences plc (AIM:STEM), the global biotechnology company focused on the commercialisation of stem cells and stem cell technologies in research and novel cell-based therapies, today announces that David A. Dodd is to become Non-Executive Chairman with Michael Dexter stepping down to become... Read More
12/11/2006
ATLANTA, GA (December 11, 2006) Don P. Giddens, Ph.D., dean of Georgia Institute of Technology’s College of Engineering, and Eric Tomlinson, DSc, Ph.D., President and CEO of Altea Therapeutics, are the 2007 winners of the Biomedical Industry Growth Awards.They will be honored at the G... Read More
11/17/2006
Charlottesville, VA November 17, 2006 – An Atlanta company emerged as the winner of the Early-Stage Shootout at the 2006 Southeastern BIO Investor Forum, which took place earlier in November at the InterContinental Buckhead Hotel in Atlanta, Georgia.The winner, Transfusion & Transplan... Read More
11/16/2006
ATLANTA, GA -- (MARKET WIRE) -- 11/16/2006 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced winning the "Best Partnership Alliance of the Year" award with AstraZeneca at the Annual Scrip Awards Dinner on Wednesd... Read More
11/7/2006
ST. LOUIS - Missouri voters sent a message Tuesday that they want to be treated equally with other Americans when it comes to their medical care by passing Amendment 2, the Missouri Stem Cell Research and Cures Initiative. The Amendment protects equal access to any federally approved stem cell treat... Read More
10/25/2006
Stem Cell Sciences plc (AIM:STEM), the global biotechnology company focused on the commercialisation of stem cells and stem cell technologies in research and novel cell-based therapies, is pleased to announce that it has signed an exclusive license agreement with Millipore Corporation to develop and... Read More
10/17/2006
Arlington, VA (October 17, 2006) - Concerned by recent attacks on teaching evolution in school systems around the nation, the Biotechnology Institute says the siege on evolution in Kansas, Ohio, Michigan, and many other states is compromising the quality of US public science education, stifling scie... Read More
10/17/2006
October 17, 2006 ATLANTA, GA - GeoVax, Inc., a privately held biotechnology Company based in Atlanta, Georgia, has merged with Dauphin Technology, Inc. (“Dauphin”), a publicly traded Company based in Schaumburg, Illinois which, upon completion of the merger, changed its name to GeoVax Labs... Read More
10/10/2006
Stem Cell Sciences plc (AIM:STEM), the global biotechnology company focused on the commercialisation of stem cells and stem cell technologies in research and novel cell-based therapies, is pleased to announce the appointment of David A Dodd to the Stem Cell Sciences' Board as Non-executive Director ... Read More
9/30/2006
(ATLANTA, September 20, 2006) – A statewide poll conducted on behalf of the Georgia Biomedical Partnership demonstrates that a significant majority of Georgia registered voters supports embryonic stem cell research and therapeutic cloning. The poll also shows Georgians overwhelmingly oppose reproduc... Read More
9/29/2006
Atlanta, GA (September 29, 2006) – The 6th Annual Georgia Life Sciences Summit, Wednesday, October 4, will begin with a one-of-a-kind presentation featuring the first-ever Georgia Life Sciences Industry Analysis and a review of a statewide poll showing Georgia registered voters support embryonic ste... Read More
9/28/2006
Home to many of the world’s top research corporations and universities, the Southeastern United Statesfeatures a unique business environment rich in innovation, collaboration and talent dedicated to growing the life sciences industry. Often ranked as having the best overall quality of life in th... Read More
9/19/2006
Atlanta, Georgia, September 25, 2006 – NeurOp Corporation, a preclinical stage pharmaceutical company focused on next generation drugs for CNS indications, announced that it has opened facilities at EmTech Bio, a biotech incubator located on the Emory University campus. The company also announced th... Read More
9/7/2006
ATLANTA, GA – Sept. 7, 2006 – Metastatix, Inc., an Atlanta-based biopharmaceutical company developing small-molecule drugs to treat cancer and HIV, announced today it has raised a $3.6 million Series A financing round. The funds will be used for the development of initial clinical candidates... Read More
8/22/2006
(ATLANTA, August 1, 2006) – The Georgia Biomedical Partnership’s (GBP) 6th Annual Georgia Life Sciences Summit will be held October 4, 2006 at the Georgia World Congress Center in Atlanta. The Summit will focus on Advances in Biomedicine and will feature international bioscience indus... Read More
8/21/2006
Charlottesville , VA, August 17, 2006 – Southeast BIO (SEBIO) announced today it has selected 31 companies to participate in its Southeastern BIO Investor Forum, an event that brings together life sciences-based entrepreneurs and the venture capital community. The SEBIO Investor Foru... Read More
8/9/2006
ATLANTA – Governor Sonny Perdue, U.S. Senators Saxby Chambliss and Johnny Isakson, and Georgia’s congressional delegation announced today that according to initial reports, the U.S. Department of Homeland Security (DHS) has included Georgia on a short list of sites to locate the National Bio and Agr... Read More
7/24/2006
Atlanta, GA July 19, 2006 – The Petit Institute for Bioengineering and Bioscience at the Georgia Institute of Technology has formed a partnership with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) designed to stimulate cross-disciplinary, collaborative research that will ... Read More
7/20/2006
(ATLANTA, July 20, 2006) Georgia’s two US Senators, Republicans Saxby Chambliss and Johnny Isakson, voted against a bill that would increase funding from the National Institutes of Health for embryonic stem cell research.The bill, HR 810, was overwhelmingly approved by the US House in 2005 ... Read More
7/19/2006
The second annual Georgia Tech Biotechnology Career Development and Recruitment Workshop will be held on October 25, 2006. This workshop will provide company representatives with an opportunity to interact with Georgia Tech students and faculty in multiple formats.Participating... Read More
7/17/2006
To see the video please click here www.gabio.org/news_video_broadcasts.asp... Read More
7/14/2006
Today Governor Sonny Perdue announced the appointments to the Commission for Newborn Umbilical Cord Blood Research and Medical Treatment (the Cord Blood Commission) which was created by Executive Order on April 12, 2006. For a complete listing of the appointments please view the full press r... Read More
7/12/2006
May 4, 2006 -- Solvay Pharmaceuticals announced today that it was awarded a $298 million, five-year contract from the United States Department of Health and Human Services (HHS) to develop cell-based influenza vaccines and plan for domestic manufacturing capacity in the U.S.The milest... Read More
7/11/2006
Life Therapeutics has appointment Subhash C. Sarda to the role of Chief Financial Officer (CFO). Mr. Sarda will be responsible for implementing the company's strategic financial plan and finalizing Life Therapeutics listing on the NASDAQ exchange. Life Therapeutics is an international compa... Read More
5/3/2006
Giv’at Shmuel, Israel and Atlanta, Georgia, USA. - June 21, 2006 - GammaCan International (OTCBB: GCAN), and Life Therapeutics (ASX: LFE) today announced a joint effort to develop VitiGam, an innovative anti-cancer product designed to target metastatic malignant melanoma patients with Stage III and ... Read More
4/26/2006
ATLANTA, GA April 25, 2006 –Millipore Corporation (NYSE: MIL) and Serologicals Corporation (NASDAQ: SERO) announced today that their boards of directors have approved a definitive agreement whereby Millipore will acquire Serologicals for $31.55 per share in an all cash transaction. The acquis... Read More
4/13/2006
Tuesday April 13, 2006, 2:00 pm ETATLANTA, Georgia, April 13, 2006 GeoVax Inc., an Atlanta, Georgia biotechnology company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents announced the FDA [Food & Drug Administration] gran... Read More
4/12/2006
ATLANTA (April 14, 2006) -- Georgia Biomedical Partnership (GBP) President Charles Craig issued the following statement today concerning Gov. Sonny Perdue’s executive order creating the Commission for Newborn Umbilical Cord Blood Research and Medical Treatment:“Gov. Sonny Perdue to... Read More
2/28/2006
ATLANTA, Ga. (February 28, 2006) The Georgia Biomedical Partnership (GBP), the non-profit association representing the life sciences industry in Georgia, issues the following response to Georgia Senate Bills 596 and 537 as currently written:The GBP supports efforts by the sponsors of ... Read More
1/19/2006
ATLANTA - Governor Sonny Perdue announced today that Altea Therapeutics is locating its new headquarters in Atlanta, retaining more than 70 high-paying jobs in Georgia and allowing for company expansion that is expected over the next several years."Keeping Altea Therapeutics in the state and... Read More
1/18/2006
ATLANTA, GA (January 18, 2006) Each year the Georgia Biomedical Partnership recognizes individuals, companies or institutions for significant contributions to Georgia’s life sciences industry with its Biomedical Community Awards.The 2006 winners are William H. Kitchens, managing partn... Read More
1/12/2006
ATLANTA, GA (January 12, 2006) - Georgia Biomedical Partnership President Charles Craig issued the following statement on Gov. Sonny Perdue’s State of the State address:“The Georgia Biomedical Partnership applauds Gov. Perdue for identifying life sciences as a top priority for ... Read More
12/14/2005
Atlanta, Georgia, December 14, 2005 – NeurOp Corporation, an early-stage pharmaceutical company based in Atlanta, announced today that it received top honors in the Southeast BIO Early-Stage Company “Shootout ” held on December 1, 2005. The Shootout was part of the seventh annual Southeastern BIO... Read More
12/7/2005
December 7, 2005 – Oncose, Inc., a privately-held cancer diagnostic company, announced today that it has entered into an agreement to license from Genzyme Corporation certain cancer marker technology for the diagnosis of colorectal or renal cancer. The exclusive, worldwide license provides Oncose w... Read More
12/6/2005
Atlanta, GA (December 6, 2005) – The Georgia Biomedical Partnership (GBP) has launched a new, redesigned website at www.gabio.org that is easier to navigate and provides up-to-date information on the organization’s activities and news about Georgia’s in... Read More
11/30/2005
ATLANTA (November 30, 2005) — Alimera Sciences Inc., an ophthalmic pharmaceutical company, announced today that it has completed Series B financing, securing $31.8 million in venture capital. Premier venture firm Venrock Associates led the new round, and all four original Series A firms continued th... Read More
11/3/2005
Device is intended for measuring intrasac pressure during endovascular abdominal aortic aneurysm (AAA) repair and may be used as an adjunctive tool in the detection of intraoperative endoleaks.Atlanta – November 1, 2005. CardioMEMS, Inc. announced today U.S. Food and Drug Administration (FDA... Read More
9/27/2005
LEADING BIOTECHNOLOGY COMPANIES TO PARTICIPATE AT SEVENTH ANNUAL SOUTHEASTERN BIO INVESTOR FORUMWilmington, NC, September 27, 2005 – Southeast BIO (SEBIO) announced today it has selected thirtytwocompanies to participate in its Seventh Annual Southeastern BIO Investor Forum. The SEBIO In... Read More